baber/WOPTO huggingface dataset:
Patent AU-2012372822-A1 (AU)
Title: Method of forming a head plate and formation of oral care implement using the same
Inventor: MOSKOVICH ROBERT
IPC: B29C45/16
Filed: 2012-03-09
Abstract: A method of forming a head plate for enhanced cleaning action during brushing. In one embodiment, the invention can be a method of forming a head plate comprising: a) forming a mounting plate comprising a first section and a second section, the first section separated from the second section by a gap, a groove formed into the second section that extends from the gap to a cleaning element location; b) positioning the mounting plate in a mold cavity; c) injecting a molten resilient material into the mold cavity so that the molten resilient material: (1) flows into the gap; (2) flows into the groove; and (3) flows into a cleaning element chamber; and d) solidifying the molten resilient material, the solidified resilient material in the gap coupling the first and second sections of the plate together, the solidified resilient material in the cleaning element chamber forming a first resilient tooth cleaning element.
Patent AU-2012396800-A1 (AU)
Title: Oral care compositions for tooth whitening
Inventor: FEI LIN
IPC: A61Q11/00
Filed: 2012-12-14
Abstract: Described herein are oral care compositions (for tooth whitening) comprising a thickening system comprising a first thickening agent and a second thickening agent, wherein the first thickening agent comprises greater than 15 wt% of the mixture of the first and second thickening agents in the thickening system. The compositions comprise crosslinked polyvinylpyrrolidone complexed with hydrogen peroxide with a thickening system comprising silica and crosslinked polyvinylpyrrolidone.
Patent AU-2013200419-A1 (AU)
Title: Improved method for preparing dipeptidyl peptidase-IV inhibitor and intermediate
Inventor: KWAK WOO YOUNG
IPC: C07C219/10
Filed: 2013-01-25
Abstract: The present invention relates to an improved method for preparing dipeptidyl peptidase-IV inhibitor and intermediate. The present invention is able to reduce preparation costs by 5 using low cost reagents on reaction and is able to be used in mass production by improving yield.
Patent AU-2013201274-A1 (AU)
Title: Electrosurgical power control
Inventor: LORANG DOUGLAS M
IPC: A61B18/12
Filed: 2013-03-05
Abstract: A method comprising: making one or more determinations that an impedance value encountered by an electrosurgical probe is less than a threshold value; and limiting tissue necrosis to less than 200 microns by delivering power to the electrosurgical probe, in response to at least one of the one or more determinations that the impedance is less than the threshold value, according to an algorithm that generates a signal with a pulsed power profile having low power portions and high power portions, wherein the high power portions have sufficient power to treat tissue in the desired manner.
Patent AU-2013202982-A1 (AU)
Title: Heterocyclic compounds and methods for their use
Inventor: MCCARTHY THOMAS DAVID
IPC: C07D207/16
Filed: 2013-01-04
Abstract: The present invention relates to heterocyclic compounds useful for antagonising angiotensin II Type 2 (AT 2) receptor. More particularly the invention relates to pyrrolidine 5 and azetidine compounds, compositions containing them and their use in methods of treating or preventing disorders or diseases associated with AT 2 receptor function including neuropathic pain, inflammatory pain, conditions associated with neuronal hypersensitivity, impaired nerve conduction velocity, cell proliferation disorders, disorders associated with an imbalance between bone resorption and bone formation and disorders 10 associated with aberrant nerve regeneration.
Patent AU-2013203907-A1 (AU)
Title: Angiotensin II receptor antagonist for the treatment of systemic diseases in cats
Inventor: STARK MARCUS
IPC: A61K31/41
Filed: 2013-04-11
Abstract: H:\fmt\Mntenvove\NRPortbl\DCC\FMT5066112 I.DOC.I 1/0412013 The present invention relates to a method of prophylaxis or treatment of systemic diseases in cats, wherein the method comprising administration of a therapeutically effective amount of angiotensin 11 receptor 1 (AT-1) antagonist (sartan) to a cat in need of such a treatment.
Patent AU-2013204779-A1 (AU)
Title: Electrochemical analyte detection apparatus and method
Inventor: HARDING IAN
IPC: G01N33/53
Filed: 2013-04-12
Abstract: A method and apparatus for electrochemical detection of analyte in a sample makes use of a binding interaction and relies on the discovery that asymmetric distribution of a redox enzyme between two electrodes that occurs when a redox enzyme-containing reagent is 5 immobilized at the surface of one electrode can be detected as a chemical potential gradient arising from an asymmetry in the distribution of oxidized or reduced redox substrate. This chemical potential gradient can be detected potentiometrically by observing the potential difference between the electrodes in an open circuit, or amperometrically by observing the current flow between the electrodes when the circuit is closed. In both cases, the observation 10 of asymmetry can be done without the application of an external potential or current to the electrodes. WO 20091015291 PCT!IJS2008107 1073 Ccoo (Q.0 ULJ LUj Ae A du LILuJ % If x LL
Patent AU-2013221822-A1 (AU)
Title: Neutral floor cleaner
Inventor: HANSON CATHERINE
IPC: C11D3/20
Filed: 2013-02-12
Abstract: Compositions and methods for improved cleaning using neutral cleaners are disclosed. In particular, neutral pH cleaning compositions according to the invention employ a synergistic combination of water insoluble surfactants and an anionic hydrotropes capable of forming a stable, low-foaming solution. The neutral cleaning solutions provide significant benefits over water insoluble microemulsions traditionally used for neutral cleaning compositions and provide at least equivalent cleaning efficacy as non-neutral cleaning compositions.
Patent AU-2013224116-A1 (AU)
Title: Biotechnological method for producing butanol and butyric acid
Inventor: SCHIEMANN YVONNE
IPC: C12P7/16
Filed: 2013-02-22
Abstract: The present invention relates to a method for producing C4 bodies, preferably butyric acid and/or butanol, comprising the steps contacting an aqueous medium comprising an acetogenic bacterial cell in an aqueous medium with syngas and incubating the mixture obtained in step a) at a temperature between 0 and 100 °C for at least 30 minutes, wherein the aqueous medium comprises, in step b), ethanol and/or acetate at a total combined concentration is at least 0.1 gL
Patent AU-2013228018-A1 (AU)
Title: System and method of calibrating the meter of a product distribution machine
Inventor: LIU JAMES Z
IPC: A01C7/16
Filed: 2013-09-12
Abstract: Abstract of the Disclosure SYSTEM AND METHOD OF CALIBRATING THE METER 5 OF A PRODUCT DISTRIBUTION MACHINE A system and method of calibrating a meter of a product distribution machine, such as an agricultural air seeder is shown The system uses one or both of optical and mass flow sensors to measure the product flow rate, The sensors are used to 10 measure mass flow rate during a calibration process while the machine is in use, To improve sensor accuracy during the calibration process, the meter speed is changed to change the product flow rate to a rate at which the sensor accuracy is increased. Ln CC) C) I crco
Patent AU-2013237722-A1 (AU)
Title: System and method for identifying multiple paths between network nodes
Inventor: ZHOU JUNLAN
IPC: H04L12/28
Filed: 2013-10-04
Abstract: Aspects of the invention pertain to transmitting packet data across a computer network (200) . The packets may be sent via one or more distinct routes (208, 210) from a source to a destination. Each route may employ multiple routers (206) disposed along the network. Non-colliding routes are determined by transmitting pairs of probe packets along the routes. A first f4 probe packet (P1) has a maximal length, and a second probe packet (P2) has a minimal length. Depending on the order of arrival of the probe packets, the system determines whether two transport layer ports at the destination device collide (306). If there is a collision, then the system (202, 206) searches for a set of non-colliding ports (308). Once the non-colliding ports are determined, application data may be sent as packets along the different routes to those ports.
Patent AU-2013245561-A1 (AU)
Title: Laundry treatment machine with lid hinge having cam members
Inventor: PARK YOUNGBAE
IPC: D06F37/28
Filed: 2013-10-21
Abstract: Provided is a laundry treatment machine. The laundry treatment machine includes a main body, a lid, and at least one hinge part. The main body has a laundry loading hole. The lid opens and closes the laundry loading hole. The at least one 5 hinge part pivotably supports the lid with respect to the main body. The hinge part includes a hinge housing, an elastic member, a pair of cams, and a division member. The hinge housing is filled with a fluid having a certain viscosity. The elastic member is disposed inside the hinge housing. The pair of cams has contact surfaces having height differences along a circumferential direction. Here, when one of the pair of 10 cams rotates in linkage with the lid, a contact surface of the one cam slides along a contact surface of the other cam, allowing the one of the pair of cams to move. The division member is disposed between the moving cam and the elastic member to deform the elastic member according to a displacement of the moving cam, divides an inside of the hinge housing into a first space in which the elastic member is disposed and a 15 second space in which the pair of cams are disposed, and has a fluid passage such that a fluid flows between the first space and the second space. 20 h 60 36-- - -- 30 --- --- 85
Patent AU-2013248227-A1 (AU)
Title: Dialysis systems and methods
Inventor: UPDYKE PALMER DAVID
IPC: A61M1/16
Filed: 2013-10-25
Abstract: This disclosure generally relates to dialysis systems and related methods. In one aspect of the invention, a dialysis system includes a device configured so that a medical fluid can pass therethrough, and the device is adapted to remove one or more substances 5 from the medical fluid as the medical fluid passes through the device. The dialysis system can also include a sodium control system adapted to alter a sodium concentration of the medical fluid. WO 2009/064984 PCT/US200S/083554 c~226 22 0N ----- '40~ ~$V' s240 4\ 24 z 1' 7
Patent AU-2013256369-A1 (AU)
Title: Collaborative spatial positioning
Inventor: BRUEMMER DAVID J
IPC: G05D1/00
Filed: 2013-05-01
Abstract: Disparate positional data derived from one or more positional determinative resources are fused with peer-to-peer relational data to provide an object with a collaborative positional awareness. An object collects positional determinative information from one or more positional resources so to independently determine its spatial location. That determination is thereafter augmented by peer-to-peer relational information that can be used to enhance positional determination and modify behavioral outcomes.
Patent AU-2013265155-A1 (AU)
Title: Damping unit for a lift
Inventor: KOCHER HANS
IPC: B66B17/34
Filed: 2013-05-24
Abstract: A damping unit (1) for a lift, for reducing vertical oscillation of a car (2) during a standstill period, has brake‑shoe holders (8, 8') provided with brake shoes (7, 7'). The brake‑shoe holders (8, 8') are connected to an electric motor (4) via a toothed‑gearing mechanism. The damping unit (1) also comprises a spring device (6), which is configured as a metallic bending spring and is arranged between the car and a carrier structure (20) for the brake‑shoe holders (8, 8').
Patent AU-2013272177-A1 (AU)
Title: Cutting element, cutter tool and method of cutting within a borehole
Inventor: STOWE II CALVIN J
IPC: E21B10/43
Filed: 2013-05-03
Abstract: A cutting element includes a modified gilmoid having two planes defining a plurality of cutting edges thereon, and a first support extending from a central area of a first of the two planes and a second support extending from a central area of a second of the two planes. The supports are sized and positioned such that when the cutting element is resting against a planar surface such that one of the plurality of cutting edges and the first support are in contact with the planar surface the first plane forms an acute angle with the planar surface.
Patent AU-2013290297-A1 (AU)
Title: Tetrahydro-isohumulone derivatives, methods of making and using
Inventor: KONDA VEERA
IPC: C07C49/743
Filed: 2013-07-09
Abstract: The present application provides novel tetrahydro-isohumulone (THIAA) derivatives and substantially enantiomerically pure compositions and pharmaceutical formulations thereof. The application further provides methods of using the disclosed compounds and compositions to activate PPARy, inhibit inflammation, and treat conditions associated with inflammation and conditions responsive to PPARy modulation such as diabetes.
Patent AU-2013302197-A1 (AU)
Title: Method for producing molten steel having high wear resistance and steel having said characteristics
Inventor: LEIVA ILLANES RICARDO
IPC: C21D1/20
Filed: 2013-07-25
Abstract: The invention refers to a method for producing a molten steel having high wear resistance having a mainly bainitic microstructure and a suitable balance of tensile strength and hardness for pieces of large size in mining operations such as milling and grinding, the chemical composition of which, expressed in weight percentage, comprises: 0.30-0.40% of C, 0.50-1.30% of Si, 0.60-1.40% of Mn, 2.30-3.20% of Cr, 0.0-1.00% of Ni, 0.25-0.70% of Mo, 0.0-0.50% of Cu, 0.0-0.10% of A, 0.0-0.10% of Ti, 0.0-0.10% of Zr, less than 0.050% of P, less than 0.050% of S, less than 0.030% of N, optionally less than 0.050% of Nb, optionally 0.0005-0.005% of B, optionally 0.015-0.080% of rare earth metals, and residual contents of W, V, Sn, Sb, Pb and Zn of less than 0.020%, and the balance in iron. The method for producing the molten steel includes smelting and heat treatment. The smelting can be carried out in an electric arc furnace having basic or acid refractory or an electric induction furnace. Smelting in an electric arc furnace as a normal operation includes melting, oxygen insufflation, blocking, refining and deoxidation. Smelting in an electric induction furnace includes melting, refining, control of nitrogen in solution and deoxidation. Heat treatment comprises settling and tempering. The molten steel described in the invention exhibits a suitable balance of the chemical composition, tensile strength and hardenability to assure complete hardening in cast pieces of large size, typically up to 17 inches in thickness, with Brinell hardness preferably in the range of 385-495 BHN throughout the section of the piece and excellent resistance to wear by abrasion impact.
Patent AU-2013322131-A1 (AU)
Title: New anti-invasive compounds
Inventor: ROUX PIERRE
IPC: C07D401/12
Filed: 2013-09-30
Abstract: The present invention relates to a compound of formula (I): wherein A and A' independently represent a phenylene group or a pyridylene group; R
Patent AU-2013329043-A1 (AU)
Title: Devices and methods for three-dimensional internal ultrasound usage
Inventor: FEARNOT NEAL E
IPC: A61B8/12
Filed: 2013-10-11
Abstract: There are disclosed embodiments of devices and methods for ultrasound imaging, for example of the inside of a body part such as a blood vessel. In particular embodiments, a catheter has a tip chamber, within which is an ultrasound transducer mounted on a pivot mechanism, a motor for turning the transducer, and an implement for pivoting the transducer. Examples of such an implement are a second motor operating a shaft or a filament, and the pivot mechanism may be biased to return to a base position when the implement is not pivoting the transducer. In other embodiments, a mirror reflecting ultrasound signals from the transducer may be rotated and/or pivoted, using similar mechanisms.
Patent AU-2013330603-A1 (AU)
Title: Monohydrate crystal of fimasartan potassium salt, method for preparing same, and pharmacological composition comprising same
Inventor: KIM JE HAK
IPC: A61K31/506
Filed: 2013-10-11
Abstract: The present invention relates to a novel monohydrate crystal form of fimasartan potassium salt, which is excellent in moisture and temperature stability, and which has a crystal particle size easy to control and which has superior homogeneity. The present invention provides a novel fimasartan potassium salt monohydrate.
Patent AU-2013343111-A1 (AU)
Title: Anti-IL-13 receptor alpha 2 antibodies and antibody-drug conjugates
Inventor: MA DANGSHE
IPC: C07K16/28
Filed: 2013-10-30
Abstract: Disclosed herein are anti-IL-13-Rα2 antibodies and antibody drug conjugates and methods for preparing and using the same.
Patent AU-2013355079-A1 (AU)
Title: Metabolomic profiling defines oncogenes driving prostate tumors
Inventor: LODA MASSIMO
IPC: C12Q1/68
Filed: 2013-12-06
Abstract: The invention provides methods and products to identify metabolic status of Aktl and Myc in tumors, and to treat cancer. The method comprises performing an assay to measure a profile of metabolites in a prostate tumor sample obtained from a subject, wherein the metabolites are differentially produced in prostate tumors with high Aktl expression versus prostate tumors with high Myc expression; and comparing, with at least one processor, the profile of metabolites with an appropriate reference profile of the metabolites to assign an Aktl and Myc metabolic status to the sample based on results of the comparison.
Patent AU-2013359076-A1 (AU)
Title: Anoikis resistant placental stem cells and uses thereof
Inventor: ZHANG XIAOKUI
IPC: C12N15/00
Filed: 2013-12-13
Abstract: Anoikis resistant placental stem cells ( arPSCs) with increased survival in low-attachment environments, and thus can advantageously be used, e.g., in therapies based on their ability to persist for longer durations of time in an unattached state. A method of modifying placental stem cells to make them anoikis resistant, comprising contacting the placental stem cells with an effective amount of modulatory RNA molecules, such that one or more genes associated with anoikis of the placental stem cells is inhibited. Further discloses are genes that are associated with anoikis for modulation.
Patent AU-2013406764-A1 (AU)
Title: Oral care implement with cover member
Inventor: JIMENEZ EDUARDO J
IPC: A46B11/00
Filed: 2013-12-05
Abstract: An oral care implement having a cover member. In one aspect, the invention is an oral care implement comprising: a body comprising a handle and a head coupled the handle, the head comprising a first coupling element, and the handle comprising a second coupling element; a store of oral care material located within the body; an outlet located on the head; a cover member comprising a cap portion, a mounting portion, and a third coupling element, the cover member alterable between: (1) a first state in which the first and third coupling elements cooperate with one another to detachably couple the cover member to the head to seal the outlet; and (2) a second state in which the second and third coupling elements cooperate with one another to detachably couple the cover member to the handle so that the mounting portion can operate as a stand.
Patent AU-2014200241-A1 (AU)
Title: Rotating control device
Inventor: HOYER CAREL W
IPC: E21B21/08
Filed: 2014-01-15
Abstract: ROTATING CONTROL DEVICE A Drill-To-The-Limit (DTTL) drilling method variant to Managed Pressure Drilling (MPD) applies constant surface backpressure, whether the mud is circulating (choke valve open) or not (choke valve closed). Because of the constant application of surface backpressure, the DTTL method can use lighter mud weight that still has the cutting carrying ability to keep the borehole clean. The DTTL method identifies the weakest component of the pressure containment system, such as the fracture pressure of the formation or the casing shoe leak off test (LOT). With a higher pressure rated RCD, such as 5,000 psi (34,474 kPa) dynamic or working pressure and 10,000 psi (68,948 kPa) static pressure, the limitation will generally be the fracture pressure of the formation or the LOT. In the DTTL method, since surface backpressure is constantly applied, the pore pressure limitation of the conventional drilling window can be disregarded in developing the fluid and drilling programs. Using the DTTL method a deeper wellbore can be drilled with larger resulting end tubulars, such as casings and production liners, than had been capable with conventional MPD applications. (Fig. 7) 150 FLUID 10012 SOURCE T 1304 134 132
Patent AU-2014201024-A1 (AU)
Title: Positively charged water-soluble prodrugs of acetaminophen and related compounds with very fast skin penetration rate
Inventor: XU LINA
IPC: C07C211/64
Filed: 2014-02-26
Abstract: POSITIVELY CHARGED WATER-SOLUBLE PRODRUGS OF ACETAMINOPHEN AND RELATED COMPOUNDS WITH VERY FAST SKIN PENETRATION RATE The novel positively charged pro-drugs of acetaminophen, acetaminosalol, and related compounds in the general formula (1) 'Structure 1' were designed and synthesized. The positively charged amino groups of these pro-drugs not only largely increases the solubility of the drugs, but also bonds to the negative charge on the phosphate head group of membranes and pushes the pro-drug into the cytosol. The results suggest that the pro-drugs diffuses through human skin ~150 times faster than does acetaminophen, acetaminosalol, and related compounds. It takes 1-2 hours for acetaminophen and acetaminosalol, and related compounds to reach the peak plasma level when they are taken orally, but these prodrugs only took about ~50 minutes to reach the peak plasma level when they are taken transdermally. In plasma, more than 90% of these pro-drugs can be changed back to the parent drugs in a few minutes. The prodrugs can be used medicinally for treating any NSAIAs-treatable conditions in humans or animals. The prodrugs can be administered not only orally, but also transdermally for any kind of medical treatments and avoid most of the side effects of NSAIAs. Controlled transdermal administration systems of the prodrugs enables acetaminophen, acetaminosalol, and related compounds to reach constantly optimal therapeutic blood levels to increase effectiveness and reduce the side effects of acetaminophen, acetaminosalol, and related compounds. Another great benefit of transdermal administration of these pro-drugs is that administering medication, especially to children, will be much easier.
Patent AU-2014202314-A1 (AU)
Title: Removal of molecular assay interferences for nucleic acids employing buffered solutions of chaotropes
Inventor: BAKER TONY
IPC: C12Q1/68
Filed: 2014-04-29
Abstract: The present disclosure relates to methods, compositions, and systems for reducing and/or eliminating ("suppressing") undesirable effects of a masking agent on a molecular assay. In addition, the present disclosure relates to molecular assays of nucleic acids in bodily fluids and/or excretions. Suppressing undesirable effects of a masking agent may include, according to some embodiments, contacting a test sample with a composition comprising a chelator, a chelator enhancing component, and a buffer. A buffer, in some embodiments, may increase the concentration of chelators and/or chelator enhancing components that may be used without undesirable effects on a nucleic acid of interest (e.g., the integrity of the nucleic acid). In some embodiments, a buffer may enhance suppression of interference from masking agents. The amounts of the chelator(s) and the chelator enhancing component(s) may be selected such that interference of a masking agent on a molecular assay of a nucleic acid-containing test sample are suppressed.